Sucampo Reports Strong Results for First Quarter of 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
Guggenheim Reiterates Buy on Sucampo Pharma (SCMP) Following 1Q Earnings
May 4, 2016 1:07 PM EDTGuggenheim reiterated a Buy rating and $29.00 price target on Sucampo Pharmaceuticals (NASDAQ: SCMP) following the company's 1Q earnings report. SCMP reported 1Q16 diluted EPS of $0.21, in line with consensus. Management reiterated its '16 adjusted EPS guidance of $1.02 at the midpoint (consensus was $1.05).
Analyst... More
